Deception keeps saying that Wedbush (ok, he actually says Wedbrush) "leaked" the information about the foamy macrophages. That of course would require Wedbush to have non-public information. Quick, call Levi and Korsinski!!!!!!
Insignificance has posted over and over about his trading prowess, and how the key to bio investing is following the money, and to never buy and hold. Amgen went public at 18 in 1983 on the heels of Genentechs successful IPO. One year later it was 2. Positively Insignificance would have been screaming that investors should get out....... like the institutions were!!!! Amgen now trades at a split adjusted $3884.00 per share.
Am I saying that Insmed is the next Amgen. No, but some here do forget that Insmed is not simply a company that has mixed together a group of chemicals in an effort to fight cancer. They are a company that has developed a technology to make existing drugs more effective. The implications of that can be much larger than many expect over time.
Funny thing, if one googles Foamy Macrophages Insmed - all the hits come back to this message board and rehvdm. I'm not sure, but I think maybe he is the one who "leaked" the information!
Bo, I am curious to see how Lewis responds (if at all.) Best respose would be a blockbuster PR involving Arikace or IPLEX. That would shut some folks up, but not those who are paid to be here day and night.